Home > Insider Trading > Filing (0001273902-16-000289)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
772406	Cirrus Logic Inc	CRUS	Semiconductors & Related Devices (3674)	770024818

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1310422	P Jason Rhode	800 West 6Th Street Austin TX 78701	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-07	86,982	$5.55	234,077	No	4	M	Direct
Common Stock	Disposition	2016-11-07	86,982	$55.69	147,095	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2016-11-07	86,982	$0.00	86,982	$5.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-10-07	No	4	M	Direct

Footnotes

This transaction was made pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 24, 2015, as amended on May 31, 2016 and August 23, 2016. All transactions under the plan have been executed and the Rule 10b5-1 plan terminated as of November 7, 2016.
The price reported in Table I - Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.19 to $56.05. The reporting person will provide full information regarding the number of shares bought at each separate price within the ranges set forth in this footnote to any security holder of Cirrus Logic, Inc. or the staff of the SEC upon request.
Dr. Rhode continues to beneficially own 690,326 shares, which includes 543,231 shares issuable upon exercise of vested stock options held by Dr. Rhode and 147,095 shares held directly.
The option vested on a 4-year schedule: 25% of the shares became exercisable on 10/7/2010; the remaining 75% of the shares vested at a rate of 1/36th per month over the following 36 months so that the option was fully vested and exercisable on 10/7/2013. Only vested shares can be exercised under this option.